AVITA Medical, Inc.
General ticker "RCEL" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $112.0M (TTM average)
AVITA Medical, Inc. follows the US Stock Market performance with the rate: 43.0%.
Estimated limits based on current volatility of 2.3%: low 12.96$, high 13.58$
Factors to consider:
- Total employees count: 226 (-13.1%) as of 2025
- US accounted for 96.1% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Market competition, Regulatory and compliance, Supply chain disruptions, Product liability claims, Liquidity and credit risks
- Current price 108.7% above estimated high
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.49$, 6.25$]
- 2026-12-31 to 2027-12-31 estimated range: [2.57$, 6.28$]
Financial Metrics affecting the RCEL estimates:
- Positive: with PPE of -2.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Inventory ratio change, % of -1.34 <= -1.30
- Positive: Investing cash flow per share per price, % of 12.94 > 2.08
- Positive: -51.61 < Industry operating profit margin (median), % of -29.60
- Positive: Industry inventory ratio change (median), % of 0.70 <= 1.15
- Positive: Interest expense per share per price, % of 5.20 <= 10.35
Short-term RCEL quotes
Long-term RCEL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $51.57MM | $64.25MM | $71.61MM |
| Operating Expenses | $94.23MM | $120.84MM | $114.14MM |
| Operating Income | $-42.66MM | $-56.59MM | $-42.53MM |
| Non-Operating Income | $7.34MM | $-5.20MM | $-6.04MM |
| Interest Expense | $1.14MM | $5.36MM | $5.00MM |
| R&D Expense | $20.82MM | $20.36MM | $20.84MM |
| Income(Loss) | $-35.31MM | $-61.79MM | $-48.58MM |
| Taxes | $0.07MM | $0.05MM | $0.01MM |
| Net Income(Loss)* | $-35.38MM | $-61.84MM | $-48.59MM |
| Stockholders Equity | $49.06MM | $4.50MM | $-16.65MM |
| Inventory | $5.60MM | $7.27MM | $6.93MM |
| Assets | $111.64MM | $79.71MM | $56.39MM |
| Operating Cash Flow | $-38.01MM | $-48.94MM | $-31.20MM |
| Capital expenditure | $1.45MM | $9.33MM | $1.74MM |
| Investing Cash Flow | $1.61MM | $37.36MM | $12.45MM |
| Financing Cash Flow | $40.37MM | $3.51MM | $14.94MM |
| Earnings Per Share** | $-1.40 | $-2.39 | $-1.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.